Annual CAPEX
$1.52 M
-$3.67 M-70.80%
December 31, 2023
Summary
- As of February 7, 2025, ALLO annual capital expenditures is $1.52 million, with the most recent change of -$3.67 million (-70.80%) on December 31, 2023.
- ALLO annual CAPEX is now -92.93% below its all-time high of $21.45 million, reached on December 31, 2021.
Performance
ALLO CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
N/A
September 30, 2024
Summary
- ALLO quarterly capital expenditures is not available.
Performance
ALLO Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CAPEX
N/A
September 30, 2024
Summary
- ALLO TTM capital expenditures is not available.
Performance
ALLO TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ALLO CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -70.8% | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
ALLO CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -92.9% | at low | ||||
| 5 y | 5-year | -92.9% | at low | ||||
| alltime | all time | -92.9% | at low |
Allogene Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | $8000.00(-95.6%) | $489.00 K(-67.7%) |
| Dec 2023 | $1.52 M(-70.8%) | $181.00 K(+1408.3%) | $1.52 M(-49.9%) |
| Sep 2023 | - | $12.00 K(-95.8%) | $3.03 M(-6.5%) |
| Jun 2023 | - | $288.00 K(-72.2%) | $3.24 M(-25.1%) |
| Mar 2023 | - | $1.03 M(-38.8%) | $4.32 M(-16.7%) |
| Dec 2022 | $5.19 M | $1.69 M(+658.7%) | $5.19 M(+22.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $223.00 K(-83.8%) | $4.24 M(-42.5%) |
| Jun 2022 | - | $1.37 M(-27.8%) | $7.36 M(-56.4%) |
| Mar 2022 | - | $1.90 M(+158.4%) | $16.89 M(-21.3%) |
| Dec 2021 | $21.45 M | $736.00 K(-78.0%) | $21.45 M(+3.6%) |
| Sep 2021 | - | $3.35 M(-69.3%) | $20.71 M(+19.3%) |
| Jun 2021 | - | $10.90 M(+68.7%) | $17.36 M(+168.7%) |
| Mar 2021 | - | $6.46 M | $6.46 M |
FAQ
- What is Allogene Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Allogene Therapeutics?
- What is Allogene Therapeutics annual CAPEX year-on-year change?
- What is the all time high quarterly CAPEX for Allogene Therapeutics?
- What is the all time high TTM CAPEX for Allogene Therapeutics?
What is Allogene Therapeutics annual capital expenditures?
The current annual CAPEX of ALLO is $1.52 M
What is the all time high annual CAPEX for Allogene Therapeutics?
Allogene Therapeutics all-time high annual capital expenditures is $21.45 M
What is Allogene Therapeutics annual CAPEX year-on-year change?
Over the past year, ALLO annual capital expenditures has changed by -$3.67 M (-70.80%)
What is the all time high quarterly CAPEX for Allogene Therapeutics?
Allogene Therapeutics all-time high quarterly capital expenditures is $10.90 M
What is the all time high TTM CAPEX for Allogene Therapeutics?
Allogene Therapeutics all-time high TTM capital expenditures is $21.45 M